With a strong foundation in corporate leadership and investment management, Michael Corrigan is recognized for his expertise in scaling businesses and executing growth strategies. His diverse career encompasses roles as both an operator and advisor within the finance sector, where he has successfully driven strategic initiatives to enhance company performance. His experience includes significant positions at prominent firms, allowing him to cultivate extensive networks across various industries. Leveraging this background, Corrigan actively participates in discussions related to market trends and organizational development, positioning himself as a thought leader in the capital markets space.
With a strong foundation in corporate leadership and investment management, Michael Corrigan is recognized for his expertise in scaling businesses and executing growth strategies. His diverse career encompasses roles as both an operator and advisor within the finance sector, where he has successfully driven strategic initiatives to enhance company performance. His experience includes significant positions at prominent firms, allowing him to cultivate extensive networks across various industries. Leveraging this background, Corrigan actively participates in discussions related to market trends and organizational development, positioning himself as a thought leader in the capital markets space.
Growth opportunities within the capital markets shape investment decisions for Michael Corrigan, who embodies a founder mindset informed by substantial operational insight. His strategic thinking is influenced by diverse experiences that blend corporate leadership with hands-on business-building acumen. Focused on scalability, he leverages his extensive network to identify emerging trends and effectively align resources for future expansion. The combination of innovative strategies and market-driven analysis drives his approach, fostering resilience in an evolving financial landscape.
Growth opportunities within the capital markets shape investment decisions for Michael Corrigan, who embodies a founder mindset informed by substantial operational insight. His strategic thinking is influenced by diverse experiences that blend corporate leadership with hands-on business-building acumen. Focused on scalability, he leverages his extensive network to identify emerging trends and effectively align resources for future expansion. The combination of innovative strategies and market-driven analysis drives his approach, fostering resilience in an evolving financial landscape.
| Trades 1681 | Longs Won 1130/1681 67% | Profit Factor 2.8 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $671,923.28 |
| Average Win $203,272.94 | Best Trade (Sep 08) $8.54M | Sharpe Ratio -9.97 |
| Average Loss -$148,760.7 | Worst Trade (Sep 28) -$13.38M | Z-Score 1.31 (81.08%) |
| Commissions $0 | Avg. Trade Length 2y 2w 5d | Expectancy $87,857.84 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,310 | 3,879 | 3,448 | 3,017 | 2,586 | 2,155 | 1,724 | 1,293 | 862 | 431 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 37,698 | $5.25M | $12.55M | - | $7.3M | 139.11% | -1.649% |
ABBV AbbVie Inc. | 75,067 | $11.68M | $19.99M | - | $8.31M | 71.19% | +0.011% |
ABT Abbott Laboratories | 12,458 | $1.35M | $1.25M | - | -$101,395.43 | -7.53% | -1.025% |
ACN Accenture plc Class A | 42,002 | $8.16M | $7.31M | - | -$843,490.41 | -10.34% | -0.189% |
ADBE Adobe Inc. | 13,504 | $5.81M | $3.12M | - | -$2.69M | -46.32% | +0.009% |
ADM Archer-Daniels-Midland Co | 6,180 | $470,694 | $490,630.2 | - | $19,936.2 | 4.24% | -1.232% |
AMAT Applied Materials, Inc. | 9,389 | $852,446.47 | $4.76M | - | $3.91M | 458.37% | +4.149% |
AMGN Amgen Inc. | 5,198 | $1.26M | $2.17M | - | $905,751.5 | 71.62% | -0.139% |
AVB AvalonBay Communities, Inc. | 46,043 | $8.14M | $8.47M | - | $334,974.73 | 4.12% | 0.0 |
AVGO Broadcom Inc. | 17,649 | $920,119.42 | $6.36M | - | $5.44M | 591.55% | +3.137% |
AZN AstraZeneca PLC American Depositary Shares | 5,592 | $1.1M | $922,568.16 | - | -$180,286.08 | -16.35% | -0.704% |
BMY Bristol-Myers Squibb Company | 160,303 | $10.65M | $10.18M | - | -$477,319.02 | -4.48% | -0.618% |
BP BP p.l.c. Sponsored ADR | 121,997 | $3.65M | $5.36M | - | $1.72M | 47.01% | -1.058% |
CAT Caterpillar Inc. | 11,714 | $2.47M | $9.69M | - | $7.22M | 292.34% | +0.922% |
CB Chubb Limited | 27,667 | $6.31M | $9.12M | - | $2.81M | 44.48% | -0.561% |
CCI Crown Castle Inc. | 20,929 | $2.22M | $1.41M | - | -$812,597.38 | -36.55% | +0.432% |
CDNMF EGR Exploration Ltd. | 23,286 | $2,328.6 | $2,328.6 | - | - | - | 0.0 |
CL Colgate-Palmolive Company | 8,322 | $666,925.08 | $717,772.5 | - | $50,847.42 | 7.62% | -0.312% |
CLX The Clorox Company | 46,532 | $4.66M | $3.79M | - | -$865,613.71 | -18.58% | +0.135% |
CMI Cummins Inc. | 14,172 | $2.9M | $7.37M | - | $4.47M | 154.34% | +0.396% |